Literature DB >> 9735065

Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation.

G Rolla1, L Brussino, P Colagrande, E Scappaticci, M Morello, S Bergerone, A Ottobrelli, E Cerutti, S Polizzi, C Bucca.   

Abstract

BACKGROUND: Nitric oxide may be involved in the impaired oxygenation of cirrhotic patients, a condition that improves in most patients after liver transplantation.
OBJECTIVE: To compare oxygenation and nitric oxide concentrations before and after liver transplantation.
DESIGN: Before-and-after observational study.
SETTING: Academic medical center. PATIENTS: 18 patients with cirrhosis and no obvious cardiopulmonary disease who underwent successful orthotopic liver transplantation. INTERVENTION: Orthotopic liver transplantation. MEASUREMENTS: Blood gas analysis, measurement of exhaled nitric oxide, contrast-enhanced echocardiography, and pulmonary function tests.
RESULTS: Before transplantation, the mean (+/- SD) exhaled nitric oxide concentration was higher in patients than in normal controls (13 +/- 4.9 parts per billion [ppb] compared with 5.75 +/- 1.9 ppb; P < 0.001). After transplantation, the alveolar-arterial oxygen gradient significantly decreased (from 17.3 +/- 7.1 mm Hg to 9 +/- 5.2 mm Hg; P < 0.001), as did the exhaled nitric oxide concentration (from 13 +/- 4.9 ppb to 6.2 +/- 2.8 ppb; P < 0.001). The decrease in the exhaled nitric oxide concentration was significantly correlated with the decrease in the alveolar-arterial oxygen gradient (r = 0.56; P = 0.014). Five patients met the criteria for the diagnosis of the hepatopulmonary syndrome before transplantation; the syndrome was cured by transplantation.
CONCLUSIONS: The correlation between the decrease in exhaled nitric oxide concentration after liver transplantation and the improvement in oxygenation reinforces the hypothesis that nitric oxide is an important mediator of impaired oxygenation in patients with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9735065     DOI: 10.7326/0003-4819-129-5-199809010-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  28 in total

1.  Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome.

Authors:  V Jounieaux; O Leleu; I Mayeux
Journal:  Intensive Care Med       Date:  2001-06       Impact factor: 17.440

Review 2.  Hepatopulmonary syndrome.

Authors:  M B Fallon; G A Abrams
Journal:  Curr Gastroenterol Rep       Date:  2000-02

3.  Pulmonary evaluation in pediatric liver transplant candidates.

Authors:  Seyed Mohsen Dehghani; Soheyla Aleyasin; Naser Honar; Ahad Eshraghian; Sara Kashef; Mahmood Haghighat; Seyed Ali Malek-Hosseini
Journal:  Indian J Pediatr       Date:  2010-10-02       Impact factor: 1.967

Review 4.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

5.  Arterial hypoxemia and intrapulmonary vasodilatation in rat models of portal hypertension.

Authors:  Yasumi Katsuta; Xue-Jun Zhang; Masaru Ohsuga; Toshio Akimoto; Hirokazu Komeichi; Shuji Shimizu; Yoshihito Kato; Akiko Miyamoto; Katsuaki Satomura; Teruo Takano
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

Review 6.  Hepatopulmonary Syndrome.

Authors:  Yong Lv; Daiming Fan
Journal:  Dig Dis Sci       Date:  2015-03-03       Impact factor: 3.199

Review 7.  Potential Clinical Targets in Hepatopulmonary Syndrome: Lessons From Experimental Models.

Authors:  Sarah Raevens; Michael B Fallon
Journal:  Hepatology       Date:  2018-11       Impact factor: 17.425

8.  The lung in liver disease: old problem, new concepts.

Authors:  Michael B Fallon; Junlan Zhang
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

9.  Alveolar exhaled nitric oxide is elevated in hereditary hemorrhagic telangiectasia.

Authors:  Samir Gupta; Noe Zamel; Marie E Faughnan
Journal:  Lung       Date:  2008-10-24       Impact factor: 2.584

10.  The effects of flavanoid on the treatment of hepatopulmonary syndrome.

Authors:  Talha Atalay; Murat Cakir; Ahmet Tekin; Tevfik Kucukkartallar; Suleyman Kargin; Adil Kartal; Adnan Kaynak
Journal:  J Korean Surg Soc       Date:  2013-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.